# PRODUCTION OF VARIOUS STRENGTH OF INJECTABLE LMP744 FOR CLINICAL USE; POP: 02/14/2020 - 02/13/2021

> **NIH NIH N02** · IRISYS, INC. · 2020 · $512,500

## Abstract

The Contractor will manufacture injectable LMP744 at various strength under cGMP condition for clinical use including one base year and four (4) one-year options during the next five years.

## Key facts

- **NIH application ID:** 10281207
- **Project number:** 261201500009I-0-759102000003-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** ROBERT GIANNINI
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $512,500
- **Award type:** —
- **Project period:** 2020-02-14 → 2021-02-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10281207

## Citation

> US National Institutes of Health, RePORTER application 10281207, PRODUCTION OF VARIOUS STRENGTH OF INJECTABLE LMP744 FOR CLINICAL USE; POP: 02/14/2020 - 02/13/2021 (261201500009I-0-759102000003-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10281207. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*